Insider Trading & Ownership - Viridian Therapeutics Inc. (VRDN)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Viridian Therapeutics Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-09-27
Purchase
2024-09-30
7:12 pm
Viridian Therapeutics Inc.VRDNBeetham Thomas W.
Chief Operating Officer
5,000$23.41$117,0506,000
(Direct)
View
2024-09-27
Purchase
2024-09-30
7:10 pm
Viridian Therapeutics Inc.VRDNMahoney Stephen F.
President and CEO
21,400$23.33$499,26221,400
(Direct)
View
2024-09-13
Purchase
2024-09-17
9:00 pm
Viridian Therapeutics Inc.VRDNFairmount Funds Management LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund II L.P.
Director
10% Owner
1,600,000$18.75$30,000,0003,445,813
(Indirect)
View
2024-01-22
Purchase
2024-01-24
6:44 pm
Viridian Therapeutics Inc.VRDNFairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
See Remarks
10% Owner
476,190$21$9,999,9901,845,813
(Indirect)
View
2023-06-15
Sale
2023-06-20
5:23 pm
Viridian Therapeutics Inc.VRDNMeisner Lara
Chief Legal Officer
2,296$28.02$64,343104,905
(Direct)
View
2023-06-02
Sale
2023-06-06
7:41 pm
Viridian Therapeutics Inc.VRDNMeisner Lara
Chief Legal Officer
7,500$24.82$186,136221,975
(Direct)
View
2023-04-12
Purchase
2023-04-12
7:05 pm
Viridian Therapeutics Inc.VRDNMyers Scott Dunseth
Chief Executive Officer
4,000$25.37$101,479259,500
(Direct)
View
2023-03-13
Purchase
2023-03-13
4:06 pm
Viridian Therapeutics Inc.VRDNMyers Scott Dunseth
Chief Executive Officer
5,500$29.15$160,324255,500
(Direct)
View
2023-03-09
Sale
2023-03-10
4:05 pm
Viridian Therapeutics Inc.VRDNMeisner Lara
General Counsel and Secretary
29,971$29.07$871,2570
(Direct)
View
2023-02-02
Sale(A)
2023-02-07
6:35 pm
Viridian Therapeutics Inc.VRDNViolin Jonathan
Chief Executive Officer
50,000$36.8$1,840,000720,110
(Direct)
View
2023-02-02
Sale
2023-02-03
6:12 pm
Viridian Therapeutics Inc.VRDNViolin Jonathan
Chief Executive Officer
50,000$36.8$1,840,000430,905
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-26
Option Award
2024-06-28
4:25 pm
N/A
2034-06-26
Viridian Therapeutics Inc.VRDNGheuens Sarah
Director
21,000$021,000
(Direct)
View
2024-06-26
Option Award
2024-06-28
4:05 pm
N/A
2034-06-26
Viridian Therapeutics Inc.VRDNMorris Arlene
Director
21,000$021,000
(Direct)
View
2024-06-26
Option Award
2024-06-28
4:05 pm
N/A
2034-06-26
Viridian Therapeutics Inc.VRDNMoses Jennifer K.
Director
21,000$021,000
(Direct)
View
2024-06-26
Option Award
2024-06-28
4:05 pm
N/A
2034-06-26
Viridian Therapeutics Inc.VRDNHarwin Peter Evan
Director
21,000$021,000
(Indirect)
View
2024-06-26
Option Award
2024-06-28
4:05 pm
N/A
2034-06-26
Viridian Therapeutics Inc.VRDNKiselak Tomas
Director
21,000$021,000
(Indirect)
View
2024-03-28
Other
2024-04-01
6:32 pm
N/A
N/A
Viridian Therapeutics Inc.VRDNFairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Director
10% Owner
49,857$01,990,722
(Indirect)
View
2024-02-12
Option Award
2024-02-14
4:05 pm
N/A
2034-02-12
Viridian Therapeutics Inc.VRDNTousignant Jennifer
Chief Legal Officer
290,000$0290,000
(Direct)
View
2024-02-05
Option Award
2024-02-07
4:01 pm
N/A
2034-02-05
Viridian Therapeutics Inc.VRDNCiulla Thomas
Chief Medical Officer
50,000$050,000
(Direct)
View

Ownership
2024-01-12
4:31 pm
N/A
N/A
Viridian Therapeutics Inc.VRDNCiulla Thomas
Chief Medical Officer
0$0570,762
(Direct)
View
2023-11-10
Option Award
2023-11-13
5:17 pm
N/A
2033-11-10
Viridian Therapeutics Inc.VRDNHarmon Seth
See Remarks
270,000$0270,000
(Direct)
View
2023-10-30
Option Award
2023-11-01
9:05 pm
N/A
N/A
Viridian Therapeutics Inc.VRDNFairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
See Remarks
10% Owner
48,463$825.3748,463
(Indirect)
View
2023-10-30
Option Award
2023-11-01
4:35 pm
N/A
2023-10-30
Viridian Therapeutics Inc.VRDNBeetham Thomas W.
Chief Operating Officer
474,400$0474,400
(Direct)
View
2023-10-30
Option Award
2023-11-01
4:35 pm
N/A
2033-10-30
Viridian Therapeutics Inc.VRDNMahoney Stephen F.
President and CEO
1,259,400$01,259,400
(Direct)
View
2023-09-21
Option Award
2023-09-25
4:35 pm
N/A
2033-09-21
Viridian Therapeutics Inc.VRDNGheuens Sarah
Director
40,000$040,000
(Direct)
View

Ownership
2023-09-19
4:30 pm
N/A
2033-06-01
Viridian Therapeutics Inc.VRDNHarmon Seth
See Remarks
0$0175,000
(Direct)
View
2023-06-15
Exercise
2023-06-20
5:23 pm
N/A
2031-01-18
Viridian Therapeutics Inc.VRDNMeisner Lara
Chief Legal Officer
2,297$0104,905
(Direct)
View
2023-06-15
Exercise
2023-06-20
5:23 pm
N/A
N/A
Viridian Therapeutics Inc.VRDNMeisner Lara
Chief Legal Officer
2,296$23.03104,905
(Direct)
View
2023-06-14
Option Award
2023-06-16
8:00 pm
N/A
2023-06-14
Viridian Therapeutics Inc.VRDNHarwin Peter Evan
Director
20,000$020,000
(Indirect)
View
2023-06-14
Option Award
2023-06-16
7:54 pm
N/A
2033-06-14
Viridian Therapeutics Inc.VRDNMoses Jennifer K.
Director
20,000$020,000
(Direct)
View
2023-06-14
Option Award
2023-06-16
7:54 pm
N/A
2033-06-14
Viridian Therapeutics Inc.VRDNKiselak Tomas
Director
20,000$020,000
(Indirect)
View
2023-06-14
Option Award
2023-06-16
7:51 pm
N/A
2033-06-14
Viridian Therapeutics Inc.VRDNMorris Arlene
Director
20,000$020,000
(Direct)
View
2023-06-02
Exercise
2023-06-06
7:41 pm
N/A
2031-09-22
Viridian Therapeutics Inc.VRDNMeisner Lara
Chief Legal Officer
7,500$0221,975
(Direct)
View
2023-06-02
Exercise
2023-06-06
7:41 pm
N/A
N/A
Viridian Therapeutics Inc.VRDNMeisner Lara
Chief Legal Officer
1,875$14221,975
(Direct)
View
2023-06-05
Exercise
2023-06-06
7:41 pm
N/A
N/A
Viridian Therapeutics Inc.VRDNMeisner Lara
Chief Legal Officer
5,625$18.51221,975
(Direct)
View
2023-02-08
Option Award
2023-02-10
4:54 pm
N/A
2033-02-08
Viridian Therapeutics Inc.VRDNKatz Barrett
Chief Medical Officer
108,000$0108,000
(Direct)
View
2023-02-08
Option Award
2023-02-10
4:51 pm
N/A
2033-02-08
Viridian Therapeutics Inc.VRDNMelvin Carrie
COO
54,000$054,000
(Direct)
View
2023-02-08
Option Award
2023-02-10
4:49 pm
N/A
2033-02-08
Viridian Therapeutics Inc.VRDNHumer Kristian
CFO and CBO
108,000$0108,000
(Direct)
View
2023-02-08
Option Award
2023-02-10
4:47 pm
N/A
2033-02-08
Viridian Therapeutics Inc.VRDNMeisner Lara
General Counsel and Secretary
108,000$0108,000
(Direct)
View
2023-02-06
Option Award
2023-02-07
6:55 pm
N/A
2033-02-06
Viridian Therapeutics Inc.VRDNMyers Scott Dunseth
Chief Executive Officer
1,250,000$01,250,000
(Direct)
View
2023-02-02
Exercise(A)
2023-02-07
6:35 pm
N/A
N/A
Viridian Therapeutics Inc.VRDNViolin Jonathan
Chief Executive Officer
50,000$0.15720,110
(Direct)
View
2023-02-02
Exercise(A)
2023-02-07
6:35 pm
N/A
2030-09-23
Viridian Therapeutics Inc.VRDNViolin Jonathan
Chief Executive Officer
50,000$0720,110
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, Next